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Introduction
============

Osteoarthritis (OA) is a chronic, degenerative disease of the joints that primarily affects the cartilage \[[@REF1]\]. OA is the most common degenerative joint disease globally and represents a substantial health burden with notable implications for the individuals and healthcare systems affected. OA is a major cause of pain and disability amongst adults worldwide, with global estimates suggesting that 250 million people are currently affected \[[@REF2]\]. The knee joint is most commonly affected by OA, and individuals suffering from knee OA commonly experience pain, stiffness and associated loss of function in the affected knees \[[@REF2], [@REF3]\]. Knee OA is the most common reason for total knee arthroplasty (KA) in the United States \[[@REF4]\].

Diabetes mellitus (DM) refers to a group of metabolic diseases characterized by aberrant glucose metabolism and persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both \[[@REF5]\].

OA and DM are rising in prevalence globally and presently affects millions. They both share a major risk factor, obesity, but DM is beginning to be recognized as a probable independent risk factor for OA \[[@REF6]-[@REF8]\]. Peri-operative hyperglycemia has been established as a poor prognostic factor following surgery \[[@REF9]-[@REF11]\]. However, there is a paucity of studies comparing outcomes of diabetic and non-diabetic patients with knee OA who underwent KA.

We aimed to investigate possible disparities in mortality and post-surgical complications between these two patient populations.

Materials and methods
=====================

Design and data source

This study design was a retrospective cohort study involving adult hospitalizations principally for knee OA who had knee replacement procedure done in the US between January 1, 2016 and December 31, 2017. Data was sourced from the Nationwide Inpatient Sample (NIS) database for 2016 and 2017. The NIS is a database of hospital inpatient stays derived from billing data submitted by hospitals to statewide data organizations across the US, covering more than 97% of the U.S. population \[[@REF12]\]. It approximates a 20% stratified sample of discharges from U.S. community hospitals, excluding rehabilitation and long-term acute care hospitals. This dataset is weighted to obtain national estimates \[[@REF13]\]. Both the 2016 and 2017 database are entirely coded using the International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System (ICD-10-CM/PCS). In the NIS, diagnoses are divided into two separate categories: principal diagnosis and secondary diagnoses. A principal diagnosis was the main ICD-10 code for the hospitalization. Secondary diagnoses were any ICD-10 code other than the principal diagnosis.

Study population

We queried the NIS 2016 and 2017 database for patients 18 years and above who had a principal discharge diagnosis of knee OA and underwent any knee replacement procedure. Patients were excluded if they were younger than 18 years of age, or if knee OA was listed as a secondary diagnosis. This cohort was further divided based on the presence of at least one secondary discharge diagnosis of diabetes mellitus types 1 and 2. We used ICD-10-CM/PCS codes to obtain the cohort and these can be found in the appendix.

Outcome measures

The primary outcome was inpatient mortality among patients principally admitted for knee OA who had any knee replacement procedure. Secondary outcomes in this population include discharge diagnoses of non-ST segment elevation myocardial infarction (NSTEMI), sepsis, post procedure site infection, pneumonia, acute kidney failure (AKI), deep vein thrombosis (DVT), pulmonary embolism (PE), need for transfusion of blood products, complications involving orthopedic devices as well as mean length of hospitalization and mean total hospital charges.

Statistical analysis

We analyzed the data using Stata® Version 16 software (StataCorp, Texas, USA). All analyses were conducted using the weighting samples for national estimates in adjunct with Healthcare Cost and Utilization Project regulations for using the NIS database. Comorbidities were calculated as proportions of the cohort and Chi squared test was used to compare these characteristics between the diabetic and non-diabetic subgroups. Chi squared test was also used to compare tabulated grouped variables, e.g. race, insurance type and hospital bed size. Multivariate regression analysis was done to adjust for possible confounders while calculating the primary and secondary outcomes. These were found from literature review. A univariate screen was done to further confirm these factors. All p-values were 2 sided, with 0.05 as the threshold for statistical significance.

Ethical considerations

The NIS database has been completely stripped of possible patient identifiers. Since 2012, the NIS has also removed state level and hospital identifiers. This has enhanced patient protection and anonymity. This study was exempt from Institutional Review Board approval.

Results
=======

Patient characteristics

The combined NIS database for 2016 and 2017 contained over 71 million hospital discharges of which 1,479,010 (2.1%) were included in the study. These patients were adults with a principal discharge diagnosis of knee OA who underwent KA. Of this group, 317,975 (21.5%) had DM, defined by ICD-10 codes.

Patients with DM were significantly older (mean age of 67.1 vs 66.4 years, p \< 0.001) and had more co-morbidities including hypertension (72.5 vs 56.7%, p \< 0.001), smoking history (30.5 vs 28.9%, p \< 0.001), congestive heart failure (4.7 vs 2.0%, p \< 0.001) and chronic kidney disease (9.1 vs 3.5%, p \< 0.001) compared with patients without DM. Table [1](#TAB1){ref-type="table"} demonstrates the demographic characteristics of the study.

###### Patient and hospital characteristics of diabetic vs non-diabetic patients with knee osteoarthritis who had knee arthroplasty

CHF: Congestive heart failure, CKD: Chronic kidney disease, CVA: Cerebrovascular accident, IHD: Ischemic heart disease

  -------------------------------------------------- ----------------------- ----------------------------- ----------------------------------- ---------
  Variable                                           Overall n = 1,479,010   Diabetic n = 317,975 (21.5)   Non-diabetic n = 1,161,035 (78.5)   p
  Patient characteristics                                                                                                                      
  Age, mean years                                    66.5                    67.1                          66.4                                 
  Women                                              (61.5)                  (58.6)                        (62.3)                              \<0.001
  Racial distribution                                \<0.001                                                                                   
  White                                              (81.8)                  (74.6)                        (83.7)                               
  Black                                              (8.0)                   (11.3)                        (7.1)                                
  Hispanic                                           (6.1)                   (8.6)                         (5.4)                                
  Others                                             (4.1)                   (5.5)                         (3.8)                                
  Insurance type                                     \<0.001                                                                                   
  Medicaid                                           (58.8)                  (63.7)                        (57.4)                               
  Medicare                                           (4.4)                   (4.9)                         (4.3)                                
  Private                                            (36.3)                  (31.0)                        (37.8)                               
  Uninsured                                          (0.5)                   (0.4)                         (0.5)                                
  Charlson Comorbidity Index score                   \<0.001                                                                                   
  0                                                  (56.8)                  (0.0)                         (72.3)                               
  1                                                  (26.5)                  (54.8)                        (18.7)                               
  2                                                  (10.0)                  (24.0)                        (6.2)                                
  ≥3                                                 (6.7)                   (21.2)                        (2.8)                                
  Median annual income in patient's zip code, US\$   \<0.001                                                                                   
  1-43,999                                           (22.1)                  (26.0)                        (21.0)                               
  44,000-55,999                                      (26.6)                  (28.0)                        (26.2)                               
  56,000-73,999                                      (27.1)                  (26.2)                        (27.4)                               
  ≥74,000                                            (24.2)                  (19.8)                        (25.4)                               
  Co-morbidities                                                                                                                               
  Hypertension                                       (60.1)                  (72.5)                        (56.7)                              \<0.001
  Smoking history                                    (28.9)                  (30.5)                        (28.5)                              \<0.001
  CHF                                                (2.6)                   (4.7)                         (2.0)                               \<0.001
  CKD                                                (4.7)                   (9.1)                         (3.5)                               \<0.001
  Dyslipidemia                                       (45.4)                  (63.2)                        (40.5)                              \<0.001
  Obesity                                            (29.5)                  (40.5)                        (26.5)                              \<0.001
  Chronic IHD                                        (11.2)                  (18.1)                        (9.4)                               \<0.001
  Prior CVA                                          (0.4)                   (0.6)                         (0.3)                               \<0.001
  Atherosclerosis                                    (0.5)                   (0.7)                         (0.5)                               \<0.001
  Liver disease                                      (1.2)                   (1.9)                         (1.0)                               \<0.001
  Hospital characteristics                                                                                                                     
  Hospital region                                    \<0.001                                                                                   
  Northeast                                          (17.7)                  (16.3)                        (18.1)                               
  Midwest                                            (26.7)                  (26.9)                        (26.6)                               
  South                                              (35.8)                  (38.9)                        (35.0)                               
  West                                               (19.8)                  (17.9)                        (20.3)                               
  Hospital bed size, no. (%)                         \<0.001                                                                                   
  Small                                              (30.2)                  (29.0)                        (30.5)                               
  Medium                                             (28.7)                  (29.2)                        (28.6)                               
  Large                                              (41.1)                  (41.8)                        (40.9)                               
  Urban location                                     (89.6)                  (89.0)                        (89.8)                              \<0.001
  Teaching hospital                                  (60.3)                  (59.8)                        (60.4)                              0.038
  -------------------------------------------------- ----------------------- ----------------------------- ----------------------------------- ---------

Primary outcome: in-hospital mortality

The in-hospital mortality for patients with knee OA who had KA was 0.024%. There were 355 reported deaths. Patients with DM did not have higher odds of in-hospital mortality (adjusted odds ratio \[aOR\]: 0.45, 95% confidence interval \[CI\]: 0.221-0.920, p = 0.029) when adjusted for co-morbidities using multivariate logistic regression analysis.

Secondary outcomes

The total length of hospital stay, and the total hospital charges between the DM and non-DM group were compared using multivariate linear regression model. There was no mean difference in length of hospital stay (0.005, CI: \[-0.017\] - 0.028, p = 0.638) in days and hospital charge (276 (-220 - 771) in USD. DM patients had lower aOR of having NSTEMI (0.53, 95% CI: 0.369 - 0.750, p \< 0.001), sepsis (0.64, 95% CI: 0.449 - 0.924, p = 0.017), deep vein thrombosis (0.67, 95% CI: 0.546 - 0.822, p \< 0.001), and need for transfusion of blood products (0.90, 95% CI: 0.823 - 0.993, p = 0.034. Detailed outcomes are provided in Table [2](#TAB2){ref-type="table"}.

###### Clinical outcomes in hospitalizations comparing diabetic vs non-diabetic patients principally admitted for knee osteoarthritis who had knee arthroplasty

\* = Statistically significant, \# = mean difference

aOR: adjusted odds ratio, CI: Confidence interval, NSTEMI: Non-ST segment elevation myocardial infarction.

  ---------------------------------------- ---------- -------------- ---------------------------- -----------
  Outcome                                  Diabetic   Non-diabetic   aOR (95% CI)                 p
  Primary outcome                                                                                 
  In hospital mortality                    105        250            0.45 (0.221 - 0.920)         0.029\*
  Secondary outcomes                                                                              
  Length of stay, mean days                2.6        2.3            0.005^\#^ (-0.017 - 0.028)   0.638
  Total hospital charges, mean USD         61444      58817          276^\#^ (-220 - 771)         0.275
  NSTEMI                                   320        505            0.53 (0.369 - 0.750)         \<0.001\*
  Sepsis                                   340        780            0.64 (0.449 - 0.924)         0.017\*
  Pneumonia                                1105       1955           1.00 (0.815 - 1.224)         0.992
  Post procedure infection                 160        305            1.63 (0.9260 - 2.86)         0.091
  Deep vein thrombosis                     965        3200           0.67 (0.546 - 0.822)         \<0.001\*
  Pulmonary embolism                       830        2390           0.99 (0.779 - 1.262)         0.941
  Complications from orthopedic device     695        3075           0.97 (0.764 - 1.243          0.832
  Need for transfusion of blood products   6635       17575          0.90 (0.823 - 0.993)         0.034\*
  Acute kidney failure                     10455      14285          1.03 (0.952 - 1.117)         0.445
  Pressure related injury                  108        255            1.20 (0.713 - 2.018)         0.494
  ---------------------------------------- ---------- -------------- ---------------------------- -----------

Discussion
==========

The prevalence of DM in our study population was 21.5%, which is more than twice the estimated prevalence of DM in the general US population (10.5%) \[[@REF14]\]. This is similar with the findings of other studies, pointing towards increased risk of OA in DM patients \[[@REF6],[@REF7]\]. Over 60% of the patients with knee OA were females. This is in common with other recent studies which have associated the female gender with an increased risk of knee osteoarthritis \[[@REF15]-[@REF17]\].

Our study showed that uncomplicated DM does not have significant impact on outcomes during hospitalizations of patients with knee OA who had knee replacement. Diabetes is associated with increased risk and accelerates the progression of OA in several studies, although the confounding effect of concomitant obesity was not considered \[[@REF6]-[@REF8]\]. Schett et al. found DM to be an independent risk factor of severe OA with a hazard ratio (HR) of 2.1 (P = 0.023) after adjusting for body mass index (BMI) \[[@REF18]\].

Findings from studies conducted by Jämsen et al. and Memtsoudis et al. indicate that increased in-hospital mortality after hip and knee replacement has been linked to renal disease, cerebrovascular disease, and DM \[[@REF19],[@REF20]\]. This is at variance with our study, likely as a result of known association of DM with other chronic medical disease, especially in cases of complicated DM.

There was a statistically significant lower odds of having NSTEMI, sepsis, DVT and the need for transfusion post KA as secondary discharge diagnoses in patients with DM who had KA. There were no significant differences in odds of pneumonia, post-procedure infection, PE, AKI, pressure-related injury or complications from orthopedic devices between both cohorts. Comparatively, a study conducted by Maradit Kremers et al. showed a higher risk of prosthetic joint infection within one year of elective primary hip and knee arthroplasty in patients with either a diagnosis of DM or perioperative hyperglycemia (HR 1.55 with 95% CI of 1.11-2.16). However, just like this study, these effects did not remain statistically significant when adjusted for comorbidities for BMI, American Society of Anesthesiologist (ASA) score, and operative time \[[@REF21]\]. Similar findings were obtained from a study conducted by Schwartz et al. which showed that although hemoglobin A1C has often been used as a marker of diabetes control for risk stratification prior to joint arthroplasty, it has not been strongly linked to an elevated risk of postoperative complications \[[@REF22]\].

This study also showed that there was no significant difference in the major indices available to measure health care utilization which are total hospital charges and length of hospital stay.

This study has several strengths. First, it utilized information from the NIS, a large nationwide dataset to provide a large sample size to compare mortality outcomes even in the setting of extremely low inpatient mortality rate associated elective joint arthroplasty. Second, the nature of the database provides insight on the comparison of baseline demographics and hospital outcomes between knee OA hospitalizations with or without DM to statistically significant levels.

There are some limitations to this study. There was non-randomization as a result of the nature of the NIS database. This is highlighted by the difference in distribution of comorbidities in both groups. There is a possibility of interpersonal variation with coding, as the NIS is an administrative database that uses ICD-10 codes to characterize diagnoses and hospitalization events. Thus, we cannot determine if underlying disease severity of OA affected the outcome of the patients. Another limitation is that laboratory and radiologic data like blood glucose readings, or knee X-rays which could indicate underlying disease severity and inflammatory activity are not available in the NIS database.

Conclusions
===========

Among patients with knee OA who had KA, uncomplicated DM does not negatively impact in-hospital outcomes. The lower odds of complications among DM patients raises the possibility of other health benefits as a result of DM-directed management. Further research is needed in identifying these protective factors.
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###### ICD-10 CM/PCS codes

  --------------------------------------------------------- ------------------------------------
  Variable                                                  Diagnostic code
  Knee osteoarthritis                                       M17
  Knee replacement procedures                               0SRC, 0SRD, 0SRT, 0SRU, 0SRV, 0SRW
  Diabetes mellitus                                         E10, E11
  Post procedural infection                                 T814
  Pressure ulceration                                       L89
  Sepsis                                                    A40, A41, R652, T8112
  Bacterial pneumonia                                       J13, J14, J15, J16
  Non-ST elevation myocardial infarction                    I214
  Venous thromboembolism                                    I82
  Pulmonary embolism                                        I26
  Complications of internal orthopedic prosthetic devices   T84
  Transfusion of blood products                             302
  Acute kidney failure                                      N17
  --------------------------------------------------------- ------------------------------------
